Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Similar content being viewed by others 1 Introduction Semaglutide is a long-acting glucagon-like peptide-1 (GLP-1) analogue approved for the treatment of type 2 diabetes (T2D) as a once-weekly subcutaneous (s.c.) formulation and, more recently, as a once-daily oral formulation [1]
In order to generate realistic attribute levels, product characteristics and head-to-head clinical trial data were used for a new oral GLP-1 RA (orally administered semaglutide) currently under review by the Japanese Pharmaceuticals and Medical Devices Agency and the two most widely used GLP-1 RAs in Japan (injectable dulaglutide and injectable liraglutide)
GLP-1 Product Offerings Mochi has a large collection of prescription drugs for GLP-1 and non-GLP-1 medications that cover many different treatment options
Real-world weight-loss effectiveness of glucagon-like peptide-1 agonists among patients with type 2 diabetes: A retrospective cohort study
US$ 20.05
US$ 22.25
US$ 28.04
US$ 25.99
